fda glp-1 warning letters october 2025 The sent a letter to the maker of Ozempic and Wegovy over unreported potential side effects. Here's what to know September 8, 2025: FDA launches
Description
Other go through the bloodstream and then they impact things like digestion, like inflammation, like blood sugar
By mimicking a hormone in the body called GLP-1, these medications slow down gastric emptying and promote satiety, which makes it easier to stick to a healthy eating plan
The frequency and severity of gastrointestinal effects represent a significant clinical consideration
They need support that adapts as the dose, appetite, symptoms, body, and goals change
GLP-1 patches are OTC (over-the-counter) transdermal patches that claim to deliver GLP-1 drugs through the skin
Monitoring helps catch these problems early instead of assuming everything is fine because body weight is going down.
